For six years, anti-biotech activists managed to prevent the introduction of G.M. crops in India. This was largely the work of Vandana Shiva, the Oxford-educated daughter of a wealthy Indian family, ...

Johnson & Johnson (JNJ) just issued one of the weirdest profit warnings in health care. The biotech business decreased its 2026 adjusted earnings guidance to between $10.96 and $11.11 a share, from a ...

AUSTIN, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: The biotechnology industry is experiencing a subtle yet meaningful transformation that is redefining how value is ...

The interest and need are here. The authors acknowledge that cloud-based and AI-driven technologies are increasingly automating drug discovery and advancing biomedical research. The global AI market ...

The biotech sector is currently navigating some incredibly choppy waters, facing never-before-seen financial pressures and rapid market shifts. For founders, it can feel like a constant battle against ...

The data and insights highlighted in the article are drawn from the Biotech Playbook for Progress, a comprehensive resource built from a 2025 TriNetX survey of 150 biotech and pharma executives.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Moleculin Biotech is advancing multiple oncology and antiviral candidates, with recent clinical updates drawing attention from speculative biotech investors. How the pipeline is evolving, and what ...